| Serial Number | 99500515 |
| Word Mark | MOSEIC |
| Filing Date | Monday, November 17, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, February 13, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Bioavailability enhancing molecular complex as an intermediate product for use in the manufacture of pharmaceuticals for the treatment of migraines, neurological disorders and central nervous system disorders |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 13, 2026 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Axsome Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10007 |
| Event Date | Event Description |
| Monday, November 17, 2025 | NEW APPLICATION ENTERED |
| Monday, November 17, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 17, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 16, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, January 20, 2026 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 20, 2026 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 20, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 13, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 13, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 13, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |